1. Home
  2. MAIA vs CULP Comparison

MAIA vs CULP Comparison

Compare MAIA & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • CULP
  • Stock Information
  • Founded
  • MAIA 2018
  • CULP 1972
  • Country
  • MAIA United States
  • CULP United States
  • Employees
  • MAIA N/A
  • CULP N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • CULP Textiles
  • Sector
  • MAIA Health Care
  • CULP Consumer Discretionary
  • Exchange
  • MAIA Nasdaq
  • CULP Nasdaq
  • Market Cap
  • MAIA 46.7M
  • CULP 50.9M
  • IPO Year
  • MAIA 2022
  • CULP N/A
  • Fundamental
  • Price
  • MAIA $1.95
  • CULP $4.24
  • Analyst Decision
  • MAIA
  • CULP
  • Analyst Count
  • MAIA 0
  • CULP 0
  • Target Price
  • MAIA N/A
  • CULP N/A
  • AVG Volume (30 Days)
  • MAIA 283.6K
  • CULP 10.6K
  • Earning Date
  • MAIA 05-09-2025
  • CULP 06-26-2025
  • Dividend Yield
  • MAIA N/A
  • CULP N/A
  • EPS Growth
  • MAIA N/A
  • CULP N/A
  • EPS
  • MAIA N/A
  • CULP N/A
  • Revenue
  • MAIA N/A
  • CULP $213,993,000.00
  • Revenue This Year
  • MAIA N/A
  • CULP N/A
  • Revenue Next Year
  • MAIA N/A
  • CULP $5.99
  • P/E Ratio
  • MAIA N/A
  • CULP N/A
  • Revenue Growth
  • MAIA N/A
  • CULP N/A
  • 52 Week Low
  • MAIA $1.40
  • CULP $3.42
  • 52 Week High
  • MAIA $4.31
  • CULP $6.85
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 57.09
  • CULP 55.95
  • Support Level
  • MAIA $1.71
  • CULP $4.11
  • Resistance Level
  • MAIA $1.81
  • CULP $4.26
  • Average True Range (ATR)
  • MAIA 0.09
  • CULP 0.13
  • MACD
  • MAIA 0.00
  • CULP 0.02
  • Stochastic Oscillator
  • MAIA 70.59
  • CULP 67.86

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About CULP Culp Inc.

Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: